192 related articles for article (PubMed ID: 23960948)
1. Review: The role of LOXL1 in exfoliation syndrome/glaucoma.
Whigham BT; Allingham RR
Saudi J Ophthalmol; 2011 Oct; 25(4):347-52. PubMed ID: 23960948
[TBL] [Abstract][Full Text] [Related]
2. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma.
Schlötzer-Schrehardt U; Zenkel M
Exp Eye Res; 2019 Dec; 189():107818. PubMed ID: 31563608
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.
Aragon-Martin JA; Ritch R; Liebmann J; O'Brien C; Blaaow K; Mercieca F; Spiteri A; Cobb CJ; Damji KF; Tarkkanen A; Rezaie T; Child AH; Sarfarazi M
Mol Vis; 2008 Mar; 14():533-41. PubMed ID: 18385788
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
Zenkel M; Schlötzer-Schrehardt U
J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
[TBL] [Abstract][Full Text] [Related]
5. The T allele of lysyl oxidase-like 1 rs41435250 is a novel risk factor for pseudoexfoliation syndrome and pseudoexfoliation glaucoma independently and through intragenic epistatic interaction.
Guadarrama-Vallejo D; Miranda-Duarte A; Zenteno JC
Mol Vis; 2013; 19():1937-44. PubMed ID: 24068861
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of high-risk alleles in the LOXL1 gene and its association with pseudoexfoliation syndrome and exfoliation glaucoma in a Latin American population.
Jaimes M; Rivera-Parra D; Miranda-Duarte A; Valdés G; Zenteno JC
Ophthalmic Genet; 2012 Mar; 33(1):12-7. PubMed ID: 21970694
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants and cellular stressors associated with exfoliation syndrome modulate promoter activity of a lncRNA within the LOXL1 locus.
Hauser MA; Aboobakar IF; Liu Y; Miura S; Whigham BT; Challa P; Wheeler J; Williams A; Santiago-Turla C; Qin X; Rautenbach RM; Ziskind A; Ramsay M; Uebe S; Song L; Safi A; Vithana EN; Mizoguchi T; Nakano S; Kubota T; Hayashi K; Manabe S; Kazama S; Mori Y; Miyata K; Yoshimura N; Reis A; Crawford GE; Pasutto F; Carmichael TR; Williams SE; Ozaki M; Aung T; Khor CC; Stamer WD; Ashley-Koch AE; Allingham RR
Hum Mol Genet; 2015 Nov; 24(22):6552-63. PubMed ID: 26307087
[TBL] [Abstract][Full Text] [Related]
8. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
[TBL] [Abstract][Full Text] [Related]
9. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
[TBL] [Abstract][Full Text] [Related]
10. Development of novel LOXL1 genotyping method and evaluation of LOXL1, APOE and MTHFR polymorphisms in exfoliation syndrome/glaucoma in a Greek population.
Chiras D; Tzika K; Kokotas H; Oliveira SC; Grigoriadou M; Kastania A; Dima K; Stefaniotou M; Aspiotis M; Petersen MB; Kroupis C; Kitsos G
Mol Vis; 2013; 19():1006-16. PubMed ID: 23687437
[TBL] [Abstract][Full Text] [Related]
11. Lysyl Oxidase Like 1: Biological roles and regulation.
Greene AG; Eivers SB; Dervan EWJ; O'Brien CJ; Wallace DM
Exp Eye Res; 2020 Apr; 193():107975. PubMed ID: 32070696
[TBL] [Abstract][Full Text] [Related]
12. Exfoliation syndrome and exfoliation glaucoma-associated LOXL1 variations are not involved in pigment dispersion syndrome and pigmentary glaucoma.
Rao KN; Ritch R; Dorairaj SK; Kaur I; Liebmann JM; Thomas R; Chakrabarti S
Mol Vis; 2008 Jul; 14():1254-62. PubMed ID: 18618003
[TBL] [Abstract][Full Text] [Related]
13. Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.
Angelilli A; Ritch R
Middle East Afr J Ophthalmol; 2009 Jan; 16(1):35-40. PubMed ID: 20142958
[TBL] [Abstract][Full Text] [Related]
14. Association of LOXL1 gene polymorphisms with exfoliation syndrome/glaucoma and primary open angle glaucoma in a Turkish population.
Kasım B; İrkeç M; Alikaşifoğlu M; Orhan M; Mocan MC; Aktaş D
Mol Vis; 2013; 19():114-20. PubMed ID: 23378724
[TBL] [Abstract][Full Text] [Related]
15. Analysis of genetically determined gene expression suggests role of inflammatory processes in exfoliation syndrome.
Hirbo JB; Pasutto F; Gamazon ER; Evans P; Pawar P; Berner D; Sealock J; Tao R; Straub PS; Konkashbaev AI; Breyer MA; Schlötzer-Schrehardt U; Reis A; Brantley MA; Khor CC; Joos KM; Cox NJ
BMC Genomics; 2023 Feb; 24(1):75. PubMed ID: 36797672
[TBL] [Abstract][Full Text] [Related]
16. From epidemiology to lysyl oxidase like one (LOXL1) polymorphisms discovery: phenotyping and genotyping exfoliation syndrome and exfoliation glaucoma in Iceland.
Jonasson F
Acta Ophthalmol; 2009 Aug; 87(5):478-87. PubMed ID: 19664108
[TBL] [Abstract][Full Text] [Related]
17. Lysyl oxidase-like 1 gene in the reversal of promoter risk allele in pseudoexfoliation syndrome.
Dubey SK; Hejtmancik JF; Krishnadas SR; Sharmila R; Haripriya A; Sundaresan P
JAMA Ophthalmol; 2014 Aug; 132(8):949-55. PubMed ID: 24809751
[TBL] [Abstract][Full Text] [Related]
18. The association of LOXL1 polymorphisms with exfoliation syndrome/glaucoma: Meta-analysis.
Ji QS; Qi B; Wen YC; Liu L; Guo XL; Yu GC; Zhong JX
Int J Ophthalmol; 2015; 8(1):148-56. PubMed ID: 25709925
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of LOXL1 polymorphisms in exfoliation syndrome in the Uygur population.
Mayinu ; Chen X
Mol Vis; 2011; 17():1734-44. PubMed ID: 21738402
[TBL] [Abstract][Full Text] [Related]
20. LOXL1 expression in lens capsule tissue specimens from individuals with pseudoexfoliation syndrome and glaucoma.
Khan TT; Li G; Navarro ID; Kastury RD; Zeil CJ; Semchyshyn TM; Moya FJ; Epstein DL; Gonzalez P; Challa P
Mol Vis; 2010 Nov; 16():2236-41. PubMed ID: 21139690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
